Your browser doesn't support javascript.
loading
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.
Shah, Manish A; Kortmansky, Jeremy; Motwani, Monica; Drobnjak, Marija; Gonen, Mithat; Yi, Sandy; Weyerbacher, Amanda; Cordon-Cardo, Carlos; Lefkowitz, Robert; Brenner, Baruch; O'Reilly, Eileen; Saltz, Leonard; Tong, William; Kelsen, David P; Schwartz, Gary K.
Affiliation
  • Shah MA; Department of Medicine, Division of Solid Tumor Oncology, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Clin Cancer Res ; 11(10): 3836-45, 2005 May 15.
Article in En | MEDLINE | ID: mdl-15897584
Search on Google
Database: MEDLINE Main subject: Camptothecin / Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2005 Type: Article Affiliation country: United States
Search on Google
Database: MEDLINE Main subject: Camptothecin / Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2005 Type: Article Affiliation country: United States